Glenmark Pharmaceuticals
GLENMARK.NS
$12.95
Share price
-0.09%
Change (1 day)
104.58%
Change (1 year)
Categories
P/S ratio for Glenmark Pharmaceuticals (GLENMARK.NS)
P/S ratio as of April 2024 (TTM): 2.46
According to Glenmark Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.46194. At the end of 2023 the company had a P/S ratio of 1.95.
P/S ratio history for Glenmark Pharmaceuticals from 2012 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.95 | 98.7% |
| 2022 | 0.9830 | -20.27% |
| 2021 | 1.23 | -6.98% |
| 2020 | 1.33 | 40.46% |
| 2019 | 0.9437 | -53.87% |
| 2018 | 2.05 | 10.39% |
| 2017 | 1.85 | -34.61% |
| 2016 | 2.83 | -21.58% |
| 2015 | 3.61 | 15.69% |
| 2014 | 3.12 | 26.21% |
| 2013 | 2.47 | -15.91% |
| 2012 | 2.94 |